Beersheba, Israel

Yana Seryi

This inventor holds 1 USPTO granted patent. Top assignee: Chemagis Ltd.. Active years: 2009.


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yana Seryi: Innovator in Letrozole Production

Introduction

Yana Seryi is a notable inventor based in Beersheba, IL. She has made significant contributions to the field of pharmaceuticals, particularly in the production of letrozole, a medication used in the treatment of breast cancer. Her innovative approach has led to the development of a unique method for synthesizing this important drug.

Latest Patents

Yana Seryi holds a patent for a process related to the production of letrozole. The patent outlines a method that involves reacting an activated bis-(4-cyanophenyl)-methane with a triazole to produce letrozole. Additionally, the patent includes a purification process for letrozole, which can involve selective precipitation from a reaction mixture and/or multiple crystallizations. This innovation not only enhances the efficiency of letrozole production but also ensures the high purity of the final product.

Career Highlights

Yana Seryi is associated with Chemagis Ltd., where she applies her expertise in pharmaceutical chemistry. Her work has been instrumental in advancing the methods used in drug production, particularly in the synthesis of letrozole. With her dedication and innovative mindset, she continues to contribute to the field of pharmaceuticals.

Collaborations

Yana collaborates with talented professionals in her field, including Oded Friedman and Boris Freger. These partnerships enhance her research and development efforts, leading to more effective solutions in drug production.

Conclusion

Yana Seryi's contributions to the pharmaceutical industry, particularly through her patent on letrozole production, highlight her role as an innovative inventor. Her work not only advances drug manufacturing processes but also plays a crucial role in improving treatment options for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…